Normalising glycerophospholipids has been shown to corrects CD4 + ve T cell signalling and functional defects as well as decreasing anti-double stranded DNA antibody production by autologous B cells in SLE patients43. This evidence concerns the gene CD4 and systemic lupus erythematosus.